Ligand Pharmaceuticals Inc · Depreciation & Amortization

Latest reported$34.32Mperiod endingJun 30, 2026

LGND Depreciation & Amortization ($2.50M → $34.32M)

Annual Depreciation & Amortization

High-resolution chart · PNG

LGND depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	33,775,000
Dec 31, 2024	35,239,000
Dec 31, 2023	36,521,000
Dec 31, 2022	43,394,000
Dec 31, 2021	50,946,000
Dec 31, 2020	27,966,000
Dec 31, 2019	43,731,000
Dec 31, 2018	14,718,000
Dec 31, 2017	11,714,000
Dec 31, 2016	11,290,000
Dec 31, 2015	2,627,000
Dec 31, 2014	2,657,000
Dec 31, 2013	2,663,000
Dec 31, 2012	2,727,000
Dec 31, 2011	2,790,000
Dec 31, 2010	2,212,000
Dec 31, 2009	3,134,000
Dec 31, 2008	1,052,000
Dec 31, 2007	2,615,000
Dec 31, 2006	16,217,000
Dec 31, 2005	18,707,000
Dec 31, 2004	15,275,000
Dec 31, 2003	14,280,000
Dec 31, 2002	10,472,000
Dec 31, 2001	6,573,000
Dec 31, 2000	6,973,000
Dec 31, 1999	7,400,000
Dec 31, 1998	7,700,000
Dec 31, 1997	9,800,000
Dec 31, 1996	9,400,000
Dec 31, 1995	3,700,000
Dec 31, 1994	2,500,000